Evidence map›Paper›PMID 38764672›Full record

ReviewACS omega2024

A Comprehensive Review on Benzofuran Synthesis Featuring Innovative and Catalytic Strategies.

Aqsa Mushtaq, Ameer Fawad Zahoor, Sajjad Ahmad, Muhammad Jawwad Saif, Atta Ul Haq, Samreen Gul Khan, Aamal A Al-Mutairi, Ali Irfan, Sami A Al-Hussain, Magdi E A Zaki

Abstract readReview
In one paragraph

Review in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Aqsa MushtaqDepartment of Chemistry, Government College University Faisalabad, 38000 Faisalabad, Pakistan.
Ameer Fawad ZahoorDepartment of Chemistry, Government College University Faisalabad, 38000 Faisalabad, Pakistan.ORCID https://orcid.org/0000-0003-2127-8848
Sajjad AhmadDepartment of Chemistry, University of Engineering and Technology Lahore, Faisalabad Campus, 38000 Faisalabad, Pakistan.
Muhammad Jawwad SaifDepartment of Applied Chemistry, Government College University Faisalabad, 38000 Faisalabad, Pakistan.ORCID https://orcid.org/0000-0002-9589-876X
Atta Ul HaqDepartment of Chemistry, Government College University Faisalabad, 38000 Faisalabad, Pakistan.ORCID https://orcid.org/0000-0003-2975-6381
Samreen Gul KhanDepartment of Chemistry, Government College University Faisalabad, 38000 Faisalabad, Pakistan.
Aamal A Al-MutairiDepartment of Chemistry, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia.
Ali IrfanDepartment of Chemistry, Government College University Faisalabad, 38000 Faisalabad, Pakistan.ORCID https://orcid.org/0000-0002-8977-3303
Sami A Al-HussainDepartment of Chemistry, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia.
Magdi E A ZakiDepartment of Chemistry, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Benzofurans have intrigued both pharmaceutical researchers and chemists owing to the medicinal usage of their derivatives against copious disease-causing agents (i.e., bacteria, viruses, and tumors). These heterocyclic scaffolds are pervasively encountered in a number of natural products and drugs. The ever-increasing utilization of benzofuran derivatives as pharmaceutical agents persuaded the chemists to devise novel and facile methodological approaches to assemble the biologically potent benzofuran nucleus. This review summarizes the current developments regarding the innovative synthetic routes and catalytic strategies to procure the synthesis of benzofuran heterocycles with their corresponding mechanistic details, reported by several research groups during 2021-2023.

Identifiers

PMID38764672
PMCPMC11097366

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.